Showing posts with label Bydureon BCise (exenatide) for Patients with Type-2 Diabetes. Show all posts
Showing posts with label Bydureon BCise (exenatide) for Patients with Type-2 Diabetes. Show all posts
Thursday, November 9, 2017

FDA Approves Once-Weekly Bydureon BCise (exenatide) for Patients with Type-2 Diabetes

›
 In continuation of my update on exenatide . AstraZeneca announced that the US Food and Drug Administration (FDA) has approved ...